Cargando…
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
We are currently approaching three years since the beginning of the coronavirus disease 2019 (COVID-19) pandemic. SARS-CoV-2 has caused extensive disruptions in everyday life, public health, and the global economy. Thus far, the vaccine has worked better than expected against the virus. During the p...
Autores principales: | Chakraborty, Chiranjib, Bhattacharya, Manojit, Dhama, Kuldeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054865/ https://www.ncbi.nlm.nih.gov/pubmed/36992266 http://dx.doi.org/10.3390/vaccines11030682 |
Ejemplares similares
-
A call for a novel and next-generation vaccine against monkeypox disease
por: Bhattacharya, Manojit, et al.
Publicado: (2022) -
Artificial intelligence–enabled clinical trials might be a faster way to perform rapid clinical trials and counter future pandemics: lessons learned from the COVID-19 period
por: Chakraborty, Chiranjib, et al.
Publicado: (2023) -
Monkeypox virus vaccine evolution and global preparedness for vaccination
por: Chakraborty, Chiranjib, et al.
Publicado: (2022) -
A novel mutation-proof, next-generation vaccine to fight against upcoming SARS-CoV-2 variants and subvariants, designed through AI enabled approaches and tools, along with the machine learning based immune simulation: A vaccine breakthrough
por: Bhattacharya, Manojit, et al.
Publicado: (2023) -
Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)